Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Novo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival. Amgen is among the leaders ...
1 hour ago